X4 Pharmaceuticals Defies Odds with Q1 2025 Turnaround Amid Market Challenges
X4 Pharmaceuticals Inc. has defied market expectations by beating Q1 2025 estimates, achieving a remarkable turnaround amidst market challenges through strategic restructuring, innovation, and financial prudence.
3 minutes to read